Edina Sehic
Postdoctoral position at Department of Medical Cell Biology; Research group Gry Hulsart Billström
- E-mail:
- edina.sehic@uu.se
- Visiting address:
- BMC
Husargatan 3
751 23 Uppsala - Postal address:
- Box 571
751 23 UPPSALA
- ORCID:
- 0000-0003-3457-1111
Short presentation
I am a postdoctoral researcher specializing in 3D printing and regenerative medicine. My research is centered on the evaluation of biomaterials aimed at enhancing bone regeneration and repair. My work integrates bioprinting and imaging techniques, as well as in vitro and in vivo models. In addition to my work in regenerative medicine and tissue engineering, I am involved in cancer research, particularly investigating mechanosensing to identify new therapeutic targets.
Keywords
- cancer
- in vivo
- in vitro
- histology
- regenerative medicine
- 3d printing
- bone
- bioprinting
- imaging
- microsurgery
Biography
Edina Sehic is a postdoctoral researcher at the Department of Medical Cell Biology, Uppsala University working with the research groups of Gry Hulsart Billström and Paul O’Callaghan. She received her BSc in Pharmacology and MSc in molecular biology in 2016 and 2018. Further, she obtained her PhD in Medical Science from Gothenburg University in January 2024, where her thesis focused on uterine tissue engineering and translational approaches using animal models.

Publications
Recent publications
Standardizing decellularization protocols for optimized uterine tissue bioengineering
Part of REGENERATIVE THERAPY, p. 183-190, 2025
- DOI for Standardizing decellularization protocols for optimized uterine tissue bioengineering
- Download full text (pdf) of Standardizing decellularization protocols for optimized uterine tissue bioengineering
All publications
Articles, review/survey
Standardizing decellularization protocols for optimized uterine tissue bioengineering
Part of REGENERATIVE THERAPY, p. 183-190, 2025
- DOI for Standardizing decellularization protocols for optimized uterine tissue bioengineering
- Download full text (pdf) of Standardizing decellularization protocols for optimized uterine tissue bioengineering